IN188469B - - Google Patents

Info

Publication number
IN188469B
IN188469B IN420DE2000A IN188469B IN 188469 B IN188469 B IN 188469B IN 420DE2000 A IN420DE2000 A IN 420DE2000A IN 188469 B IN188469 B IN 188469B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rohne Poulenc Rorer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohne Poulenc Rorer S A filed Critical Rohne Poulenc Rorer S A
Publication of IN188469B publication Critical patent/IN188469B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN420DE2000 1995-12-22 2000-04-10 IN188469B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IN188469B true IN188469B (cg-RX-API-DMAC7.html) 2002-09-28

Family

ID=9485871

Family Applications (4)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (cg-RX-API-DMAC7.html) 1995-12-22 1996-12-20
IN420DE2000 IN188469B (cg-RX-API-DMAC7.html) 1995-12-22 2000-04-10
IN419DE2000 IN188680B (cg-RX-API-DMAC7.html) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (cg-RX-API-DMAC7.html) 1995-12-22 2000-04-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (cg-RX-API-DMAC7.html) 1995-12-22 1996-12-20

Family Applications After (2)

Application Number Title Priority Date Filing Date
IN419DE2000 IN188680B (cg-RX-API-DMAC7.html) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (cg-RX-API-DMAC7.html) 1995-12-22 2000-04-10

Country Status (40)

Country Link
US (1) US5728849A (cg-RX-API-DMAC7.html)
EP (1) EP0876362B1 (cg-RX-API-DMAC7.html)
JP (1) JP3953106B2 (cg-RX-API-DMAC7.html)
KR (1) KR100500351B1 (cg-RX-API-DMAC7.html)
CN (1) CN1103766C (cg-RX-API-DMAC7.html)
AR (1) AR005197A1 (cg-RX-API-DMAC7.html)
AT (1) ATE250593T1 (cg-RX-API-DMAC7.html)
AU (1) AU712597B2 (cg-RX-API-DMAC7.html)
BG (1) BG63204B1 (cg-RX-API-DMAC7.html)
BR (1) BR9612135A (cg-RX-API-DMAC7.html)
CA (1) CA2238884C (cg-RX-API-DMAC7.html)
CO (1) CO4520184A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ294972B6 (cg-RX-API-DMAC7.html)
DE (1) DE69630145T2 (cg-RX-API-DMAC7.html)
DK (1) DK0876362T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ2149A1 (cg-RX-API-DMAC7.html)
EA (1) EA001533B1 (cg-RX-API-DMAC7.html)
ES (1) ES2202490T3 (cg-RX-API-DMAC7.html)
FR (1) FR2742751B1 (cg-RX-API-DMAC7.html)
HU (1) HU225032B1 (cg-RX-API-DMAC7.html)
IL (1) IL124994A (cg-RX-API-DMAC7.html)
IN (4) IN186768B (cg-RX-API-DMAC7.html)
MA (1) MA26412A1 (cg-RX-API-DMAC7.html)
MX (1) MX9804688A (cg-RX-API-DMAC7.html)
MY (1) MY113934A (cg-RX-API-DMAC7.html)
NO (1) NO317358B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ324337A (cg-RX-API-DMAC7.html)
OA (1) OA10700A (cg-RX-API-DMAC7.html)
PE (1) PE25198A1 (cg-RX-API-DMAC7.html)
PL (1) PL189311B1 (cg-RX-API-DMAC7.html)
PT (1) PT876362E (cg-RX-API-DMAC7.html)
RO (1) RO116194B1 (cg-RX-API-DMAC7.html)
SK (1) SK282835B6 (cg-RX-API-DMAC7.html)
TN (1) TNSN96169A1 (cg-RX-API-DMAC7.html)
TR (1) TR199801179T2 (cg-RX-API-DMAC7.html)
TW (1) TW371659B (cg-RX-API-DMAC7.html)
UA (1) UA48205C2 (cg-RX-API-DMAC7.html)
UY (1) UY24386A1 (cg-RX-API-DMAC7.html)
WO (1) WO1997023473A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9610737B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
PL350028A1 (en) 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
SI1953162T1 (sl) * 2001-02-24 2012-09-28 Boehringer Ingelheim Pharma Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1663153A4 (en) * 2003-05-20 2011-01-05 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH A LIPOSOMAL PLATINUM COMPLEX
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
BRPI0711558A2 (pt) * 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
KR101657960B1 (ko) * 2008-08-15 2016-09-20 베링거 인겔하임 인터내셔날 게엠베하 Fab-관련 질환의 치료에 사용하기 위한 푸린 유도체
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
MX341025B (es) 2010-05-05 2016-08-04 Boehringer Ingelheim Int Gmbh * Terapia de combinacion.
PH12012502524A1 (en) 2010-06-24 2014-02-10 Boehringer Ingelheim Int Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. 荷電連結体及び共役体のためのその使用
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CN1103766C (zh) 2003-03-26
DZ2149A1 (fr) 2002-10-23
AR005197A1 (es) 1999-04-14
CZ294972B6 (cs) 2005-04-13
WO1997023473A1 (fr) 1997-07-03
JP2000502671A (ja) 2000-03-07
FR2742751A1 (fr) 1997-06-27
EP0876362B1 (fr) 2003-09-24
AU712597B2 (en) 1999-11-11
IN188470B (cg-RX-API-DMAC7.html) 2002-09-28
FR2742751B1 (fr) 1998-01-30
MA26412A1 (fr) 2004-12-20
BG102569A (en) 1999-04-30
PL189311B1 (pl) 2005-07-29
RO116194B1 (ro) 2000-11-30
TW371659B (en) 1999-10-11
SK85398A3 (en) 1998-11-04
CA2238884C (fr) 2007-02-06
BR9612135A (pt) 1999-07-13
ES2202490T3 (es) 2004-04-01
IL124994A (en) 2000-12-06
TNSN96169A1 (fr) 2005-03-15
NO982580L (no) 1998-06-05
DK0876362T3 (da) 2004-02-02
EP0876362A1 (fr) 1998-11-11
NO317358B1 (no) 2004-10-18
IN186768B (cg-RX-API-DMAC7.html) 2001-11-03
HUP9904046A3 (en) 2001-08-28
NZ324337A (en) 2000-03-27
ATE250593T1 (de) 2003-10-15
DE69630145T2 (de) 2004-07-15
KR19990076680A (ko) 1999-10-15
JP3953106B2 (ja) 2007-08-08
EA001533B1 (ru) 2001-04-23
PL327405A1 (en) 1998-12-07
SK282835B6 (sk) 2002-12-03
PE25198A1 (es) 1998-05-10
OA10700A (fr) 2002-11-27
BG63204B1 (bg) 2001-06-29
KR100500351B1 (ko) 2005-12-21
ZA9610737B (en) 1997-06-27
TR199801179T2 (xx) 1998-10-21
MY113934A (en) 2002-06-29
PT876362E (pt) 2004-02-27
UA48205C2 (uk) 2002-08-15
NO982580D0 (no) 1998-06-05
IL124994A0 (en) 1999-01-26
CO4520184A1 (es) 1997-10-15
HUP9904046A1 (hu) 2001-04-28
CN1205697A (zh) 1999-01-20
HU225032B1 (en) 2006-05-29
IN188680B (cg-RX-API-DMAC7.html) 2002-10-26
UY24386A1 (es) 2001-08-27
US5728849A (en) 1998-03-17
DE69630145D1 (de) 2003-10-30
HK1017895A1 (en) 1999-12-03
CZ196198A3 (cs) 1998-09-16
AU1180997A (en) 1997-07-17
MX9804688A (es) 1998-10-31
EA199800588A1 (ru) 1998-12-24
CA2238884A1 (fr) 1997-07-03

Similar Documents

Publication Publication Date Title
BRPI9612258B1 (cg-RX-API-DMAC7.html)
BRPI9612138B1 (cg-RX-API-DMAC7.html)
IN188680B (cg-RX-API-DMAC7.html)
EP0779527A3 (cg-RX-API-DMAC7.html)
AU1627395A (cg-RX-API-DMAC7.html)
IN184885B (cg-RX-API-DMAC7.html)
IN183639B (cg-RX-API-DMAC7.html)
IN189231B (cg-RX-API-DMAC7.html)
IN183732B (cg-RX-API-DMAC7.html)
IN178814B (cg-RX-API-DMAC7.html)
BR7501503U (cg-RX-API-DMAC7.html)
BR7502120U (cg-RX-API-DMAC7.html)
CN3029479S (cg-RX-API-DMAC7.html)
CN3031350S (cg-RX-API-DMAC7.html)
CN3032332S (cg-RX-API-DMAC7.html)
CN3031001S (cg-RX-API-DMAC7.html)
CN3033225S (cg-RX-API-DMAC7.html)
CN3034473S (cg-RX-API-DMAC7.html)
CN3031742S (cg-RX-API-DMAC7.html)
CN3031655S (cg-RX-API-DMAC7.html)
CN3034591S (cg-RX-API-DMAC7.html)
CN3035870S (cg-RX-API-DMAC7.html)
CN3035871S (cg-RX-API-DMAC7.html)
CN3030542S (cg-RX-API-DMAC7.html)
CN3031926S (cg-RX-API-DMAC7.html)